Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

Torii Pharmaceutical Co., Ltd. (TRXPF)

Compare
24.57
0.00
(0.00%)
At close: March 26 at 4:00:00 PM EDT
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
60,425,000
60,425,000
54,637,000
48,894,000
46,987,000
Cost of Revenue
33,718,000
33,718,000
29,846,000
25,516,000
22,648,000
Gross Profit
26,707,000
26,707,000
24,791,000
23,379,000
24,338,000
Operating Expense
19,906,000
19,906,000
19,750,000
17,834,000
19,679,000
Operating Income
6,801,000
6,801,000
5,041,000
5,545,000
4,659,000
Net Non Operating Interest Income Expense
357,000
357,000
287,000
167,000
144,000
Pretax Income
6,725,000
6,725,000
5,593,000
5,722,000
4,767,000
Tax Provision
1,682,000
1,682,000
1,473,000
1,778,000
1,392,000
Net Income Common Stockholders
5,042,000
5,042,000
4,119,000
3,944,000
3,374,000
Diluted NI Available to Com Stockholders
5,042,000
5,042,000
4,119,000
3,944,000
3,374,000
Basic EPS
179.38
179.38
146.60
140.39
120.13
Diluted EPS
179.38
179.38
146.60
140.39
120.13
Basic Average Shares
28,109.43
28,109.43
28,103.23
28,096.79
28,090
Diluted Average Shares
28,111.23
28,109.43
28,103.23
28,096.79
28,090
Total Operating Income as Reported
6,798,000
6,798,000
5,035,000
5,540,000
4,656,000
Total Expenses
53,624,000
53,624,000
49,596,000
43,350,000
42,327,000
Net Income from Continuing & Discontinued Operation
5,042,000
5,042,000
4,119,000
3,944,000
3,374,000
Normalized Income
5,392,250
5,392,250
3,941,624
3,859,253
3,471,704
Interest Income
357,000
357,000
287,000
167,000
144,000
Net Interest Income
357,000
357,000
287,000
167,000
144,000
EBIT
6,725,000
6,725,000
5,593,000
5,722,000
4,767,000
EBITDA
7,133,000
7,133,000
6,052,000
6,176,000
5,180,000
Reconciled Cost of Revenue
33,718,000
33,718,000
29,846,000
25,516,000
22,648,000
Reconciled Depreciation
408,000
408,000
459,000
454,000
413,000
Net Income from Continuing Operation Net Minority Interest
5,042,000
5,042,000
4,119,000
3,944,000
3,374,000
Total Unusual Items Excluding Goodwill
-467,000
-467,000
241,000
123,000
-138,000
Total Unusual Items
-467,000
-467,000
241,000
123,000
-138,000
Normalized EBITDA
7,600,000
7,600,000
5,811,000
6,053,000
5,318,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-116,750
-116,750
63,624
38,253
-40,296
12/31/2021 - 3/15/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade